MedAI Verdict
AI medical scribes

AI Medical Scribe

ThetaRho RISA logo

ThetaRho RISA

by ThetaRho  ·  founded 2023  ·  US

Last verified

Clinical research assistant that summarizes patient charts and answers clinician queries, sold on an on-premises appliance.

At a glance

Pricing
No public price. Appliance tiers CIS-1, CIS-2 and CIS-3 are listed without prices. Demo via Calendly
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2023
HQ
US
On this page

Independent score  ·  By our public rubric

10/100Tracked

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    0/13

    No public HIPAA/SOC2/BAA attestation

  • Clinical Integration
    0/38.2

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    6/18

    Seed-stage or unfunded

  • Sentiment & Transparency
    2.5/5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA0/13

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/21

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/12

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    Seed-stage or unfunded

  • Years in market3/6

    Founded 2023 (3 years)

Sentiment & Transparency

  • Pricing transparency3/5

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

Clinical research assistant that summarizes patient charts and answers clinician queries, sold on an on-premises appliance.

No public price. Appliance tiers CIS-1, CIS-2 and CIS-3 are listed without prices. Demo via Calendly.

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, ThetaRho RISA record, https://medaiverdict.com/tools/thetarho, version November 2, 2026

Bottom line

ThetaRho's RISA (Clinical Research Assistant) answers clinician questions over a patient's chart, summarizes it and drafts documents for physician approval. The vendor homepage now sells RISA bundled on every unit of its Clinical Intelligence System (CIS), an on-premises appliance that runs AI models inside the customer's network. The appliance starts at a tier for one to three providers and runs up to a health system or research network. Research teams and health-system IT groups are the audience the homepage frames. The price is not published.

What does RISA do, according to its page?

The RISA page describes four functions. Retrieve answers questions from vitals, labs, medications, notes, imaging and documents drawn from the EHR, CommonWell, TEFCA and health information exchanges, reading PDFs, CCDAs and scans. Investigate searches literature, guidelines and drug databases with citations. Synthesize produces pre-visit and since-last-visit summaries, timelines and care gaps. Act drafts notes, referral summaries, prior-authorization justifications and billing recommendations, with physician approval required.

The page says every claim is marked grounded (traced to the chart) or ungrounded (needs validation), and lists editions for cardiology, oncology, primary care, gynecology, pulmonology and gastroenterology.

What is the CIS appliance?

The homepage says CIS "runs local AI models and apps on one appliance inside your network". CIS-1 is for one to three providers, CIS-2 for a department and CIS-3 for a health system or research network. The vendor says PHI never leaves the network and air-gapped operation is possible, and that AI runs on the appliance's GPUs with fixed costs and no per-token billing. A demo is booked through Calendly.

Which EHRs, and what security status?

The vendor names no EHR on its homepage, About page or RISA page, only CommonWell, TEFCA and connected exchanges, and it does not name FHIR. CB Insights calls the product FHIR-native. HIPAA and SOC 2 status is unconfirmed. Neither FDA nor CE status is stated.

Who is ThetaRho?

Search profiles from CB Insights and Nasdaq Private Market place ThetaRho.ai in San Jose, California, founded in 2023, with Kannan Govindarajan as CEO and founder and Ramani Narayan on the board. PitchBook lists a $750K early-stage deal and ten employees. A CB Insights item mentions an athenahealth Marketplace partnership that the vendor's site does not confirm. The homepage carries three unnamed physician testimonials.

The verdict

Whether RISA is still sold on its own, or only inside a CIS appliance, is not stated on the homepage. The buyer the pages describe is a team that wants chart questions answered by models running on its own network.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Appliance tiers CIS-1, CIS-2 and CIS-3 are listed without prices. Demo via Calendly

Source: vendor pricing page. Last checked November 2, 2026.

Who builds it

ThetaRho RISA (ThetaRho) was founded in 2023 in US, putting it 3 years into market.